Metropolitan Life Insurance Company (MetLife)’s Medtronic MDT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-53,628	Closed	-$4.67M	–	1255
2024 Q1	$4.67M	Sell	53,628 -530	-1%	-$45.2K	0.2%	89
2023 Q4	$4.46M	Sell	54,158 -917	-2%	-$69.9K	0.21%	85
2023 Q3	$4.32M	Sell	55,075 -2,903	-5%	-$243K	0.22%	80
2023 Q2	$5.11M	Buy	+57,978	New	+$4.99M	0.25%	76
2023 Q1	–	Sell	-76,878	Closed	-$5.97M	–	2407
2022 Q4	$5.97M	Sell	76,878 -2,228	-3%	-$181K	0.27%	82
2022 Q3	$6.39M	Sell	79,106 -1,697	-2%	-$153K	0.3%	64
2022 Q2	$7.25M	Sell	80,803 -2,171	-3%	-$220K	0.32%	62
2022 Q1	$9.21M	Sell	82,974 -70,819	-46%	-$7.48M	0.33%	59
2021 Q4	$15.9M	Sell	153,793 -4,275	-3%	-$495K	0.22%	76
2021 Q3	$19.8M	Buy	+158,068	New	+$20.5M	0.29%	61
2021 Q2	–	Sell	-166,421	Closed	-$19.7M	–	2810
2021 Q1	$19.7M	Sell	166,421 -7,988	-5%	-$936K	0.29%	58
2020 Q4	$20.4M	Sell	174,409 -9,072	-5%	-$999K	0.31%	56
2020 Q3	$19.1M	Sell	183,481 -7,726	-4%	-$776K	0.32%	56
2020 Q2	$17.5M	Sell	191,207 -11,666	-6%	-$1.12M	0.31%	57
2020 Q1	$18.3M	Sell	202,873 -775	-0.4%	-$82.5K	0.38%	50
2019 Q4	$23.1M	Buy	203,648 +4,145	+2%	+$455K	0.37%	51
2019 Q3	$21.7M	Buy	199,503 +460	+0.2%	+$48K	0.37%	50
2019 Q2	$19.4M	Buy	199,043 +15,724	+9%	+$1.44M	0.33%	56
2019 Q1	$16.7M	Sell	183,319 -8,374	-4%	-$749K	0.3%	62
2018 Q4	$17.4M	Sell	191,693 -3,711	-2%	-$347K	0.35%	55
2018 Q3	$19.2M	Buy	+195,404	New	+$18.1M	0.33%	57
2015 Q1	–	Sell	-546,558	Closed	-$39.5M	–	2346
2014 Q4	$39.5M	Sell	546,558 -7,571	-1%	-$526K	0.27%	71
2014 Q3	$34.3M	Sell	554,129 -18,730	-3%	-$1.19M	0.25%	81
2014 Q2	$36.5M	Sell	572,859 -29,564	-5%	-$1.8M	0.25%	77
2014 Q1	$37.1M	Sell	602,423 -8,172	-1%	-$476K	0.26%	74
2013 Q4	$35M	Sell	610,595 -13,208	-2%	-$749K	0.25%	81
2013 Q3	$33.2M	Sell	623,803 -11,612	-2%	-$625K	0.25%	78
2013 Q2	$32.7M	Buy	+635,415	New	+$31.4M	0.26%	72

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s MDT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Medtronic (MDT) in Q2 2024, closing a stake of 53,628 shares — an estimated $4.67M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MDT in Q2 2013 and held it in 28 quarters. The position peaked at $39.5M in Q4 2014. 2,026 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 53,628 Medtronic shares in Q2 2024, an estimated $4.67M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Medtronic in Q2 2013 and held it in 28 quarters.
Metropolitan Life Insurance Company (MetLife)'s Medtronic position peaked at $39.5M in Q4 2014.
2,026 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.